Merck and Moderna’s Intismeran Autogene Plus Keytruda Meets Phase 3 RFS and DMFS Endpoints in Resected Melanoma
FDA Grants HDE Approval to OncoSil for Distal Cholangiocarcinoma
FDA Lists More Than 1,500 AI-Enabled Medical Devices as Oncology Applications Expand
ENZAMET: Enzalutamide Maintains Long-Term Survival Benefit in mHSPC
Simplify Your ESO College Enrolment With Our New 3-Year Plan - ESO
Bridging the Care Gap: Expanding Humanitarian Access to CLL Treatment Across LMICs
Human Connection in Cancer Care with Dr. Aleksandra Filipovic - CancerWorld
oncoHUB and OncoDaily Announce Strategic Partnership to Strengthen Ukrainian Oncology
The 2026 NANETS Multidisciplinary NET Medical Symposium, organized by the North American Neuroendocrine Tumor Society (NANETS), will take place on 5–7 November 2026 at the JW Marriott Las Vegas Resort […]
